Brazil on Wednesday for the first time approved the use of a marijuana derivative to treat people suffering from epilepsy, multiple sclerosis and schizophrenia among other disorders. Directors of...
Research from the University of Manchester sheds new light on the impact of marijuana use on schizophrenia. “There was no evidence of a specific association between cannabis...
Leaf Science shares a possible link between marijuana and schizophrenia, which is now one of the primary arguments being made against legalization of recreational use. But are concerns that...
Dutch and British scientists say CBD in marijuana could be more effective than leading medications for psychotic disorders such as schizophrenia since, unlike a vast majority of...
The administration of the non-psychotropic plant constituent cannabidiol (CBD) is associated with a significant reduction in psychotic symptoms in patients with schizophrenia, according to clinical trial data...
According to a report from the National Center for Biotechnology Information, cannabidiolic acid has been shown to inhibit MDA-MB-231, a powerful human breast cancer cell. Another scientific study,...
For the second time in recent months, a scientific paper published in a peer-reviewed journal has thoroughly rebutted the present Schedule I status of cannabis under US federal law, which states...
